145 related articles for article (PubMed ID: 11549511)
1. Short-term histopathologic effects of different intracavernosal agents on corpus cavernosum and antifibrotic activity of intracavernosal verapamil: an experimental study.
Sahin M; Başar MM; Bozdoğan O; Atan A
Urology; 2001 Sep; 58(3):487-92. PubMed ID: 11549511
[TBL] [Abstract][Full Text] [Related]
2. Histopathological change of corpora cavernosa after long-term intracavernous injection.
Hwang TI; Yang CR; Ho WL; Chu HW
Eur Urol; 1991; 20(4):301-6. PubMed ID: 1814746
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity of different intracavernous vasoactive drugs on cultured endothelial cells of human corpus cavernosum penis.
Schultheiss D; Pilatz A; Gabouev AI; Schlote N; Wefer J; Mertsching H; Sohn M; Jonas U; Stief CG
Urology; 2004 Sep; 64(3):598-602. PubMed ID: 15351616
[TBL] [Abstract][Full Text] [Related]
4. Experience with intracavernosal tri-mixture for the management of neurogenic erectile dysfunction.
Chao R; Clowers DE
Arch Phys Med Rehabil; 1994 Mar; 75(3):276-8. PubMed ID: 8129578
[TBL] [Abstract][Full Text] [Related]
5. Effects of intracavernous calcium channel blockers in dogs.
Sarikaya S; Aşçi R; Aybek Z; Yilmaz AF; Büyükalpelli R; Yildiz S
Int Urol Nephrol; 1997; 29(6):673-80. PubMed ID: 9477366
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a no-needle penile injector: a preliminary study evaluating tissue penetration and its hemodynamic consequences in the rat.
Seyam RM; Bégin LR; Tu LM; Dion SB; Merlin SL; Brock GB
Urology; 1997 Dec; 50(6):994-8. PubMed ID: 9426740
[TBL] [Abstract][Full Text] [Related]
7. Electromyographic changes of corpus cavernosum due to papaverine and nitroprusside in veno-occlusive dysfunction.
Kayigil O; Atahan O; Metin A
J Urol; 1996 Oct; 156(4):1316-9. PubMed ID: 8808862
[TBL] [Abstract][Full Text] [Related]
8. Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum.
Leungwattanakij S; Bivalacqua TJ; Usta MF; Yang DY; Hyun JS; Champion HC; Abdel-Mageed AB; Hellstrom WJ
J Androl; 2003; 24(2):239-45. PubMed ID: 12634311
[TBL] [Abstract][Full Text] [Related]
9. Electrical activity of the corpus cavernosum in denervated rats.
Başar MM; Yildiz M; Başar H; Ak F; Akan H; Atan A
Int J Urol; 1999 May; 6(5):251-6. PubMed ID: 10375188
[TBL] [Abstract][Full Text] [Related]
10. Local and systemic effects of chronic intracavernous injection of papaverine, prostaglandin E1, and saline in primates.
Aboseif SR; Breza J; Bosch RJ; Benard F; Stief CG; Stackl W; Lue TF; Tanagho EA
J Urol; 1989 Aug; 142(2 Pt 1):403-8. PubMed ID: 2746759
[TBL] [Abstract][Full Text] [Related]
11. [Intracavernous pressure responses induced by electrical stimulation of penile dorsal nerves and intracavernosal drug injection in rats].
Xing JP; Cui XF; Sun JH; Li Q; Liu J; Qiu SD
Zhonghua Nan Ke Xue; 2005 Apr; 11(4):281-3, 287. PubMed ID: 15921260
[TBL] [Abstract][Full Text] [Related]
12. Intracavernosal injections and fibrosis: myth or reality?
Tal R; Mulhall JP
BJU Int; 2008 Aug; 102(5):525-6. PubMed ID: 18485038
[No Abstract] [Full Text] [Related]
13. Dual Strategy With Oral Phosphodiesterase Type 5 Inhibition and Intracavernosal Implantation of Mesenchymal Stem Cells Is Superior to Individual Approaches in the Recovery of Erectile and Cavernosal Functions After Cavernous Nerve Injury in Rats.
Martínez-Salamanca JI; Zurita M; Costa C; Martínez-Salamanca E; Fernández A; Castela A; Vaquero J; Carballido J; Angulo J
J Sex Med; 2016 Jan; 13(1):1-11. PubMed ID: 26755080
[TBL] [Abstract][Full Text] [Related]
14. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
Purvis K; Brekke I; Christiansen E
Int J Impot Res; 1996 Mar; 8(1):9-16. PubMed ID: 8735188
[TBL] [Abstract][Full Text] [Related]
15. Peyronie's-like plaque after penile injection of prostaglandin E1.
Chen J; Godschalk M; Katz PG; Mulligan T
J Urol; 1994 Sep; 152(3):961-2. PubMed ID: 8051767
[TBL] [Abstract][Full Text] [Related]
16. Erectile response to intracavernous injection of vasoactive drugs after penile prosthesis removal.
Stief CG; Gall H; Scherb W; Bähren W
Urology; 1990 Aug; 36(2):143-5. PubMed ID: 2385882
[TBL] [Abstract][Full Text] [Related]
17. Tissue angiotensin II as a modulator of erectile function. I. Angiotensin peptide content, secretion and effects in the corpus cavernosum.
Kifor I; Williams GH; Vickers MA; Sullivan MP; Jodbert P; Dluhy RG
J Urol; 1997 May; 157(5):1920-5. PubMed ID: 9112563
[TBL] [Abstract][Full Text] [Related]
18. Intracavernous injection of vasoactive drugs in the rabbit.
Stackl W; Loupal G; Holzmann A
Urol Res; 1988; 16(6):455-8. PubMed ID: 3232278
[TBL] [Abstract][Full Text] [Related]
19. Chronic papaverine treatment: the effect of repeated injections on the simian erectile response and penile tissue.
Abozeid M; Juenemann KP; Luo JA; Lue TF; Yen TS; Tanagho EA
J Urol; 1987 Nov; 138(5):1263-6. PubMed ID: 3669186
[TBL] [Abstract][Full Text] [Related]
20. A clinical comparative study on effects of intracavernous injection of sodium nitroprusside and papaverine/phentolamine in erectile dysfunction patients.
Fu Q; Yao DH; Jiang YQ
Asian J Androl; 2000 Dec; 2(4):301-3. PubMed ID: 11202421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
